Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Recommended testing for metabolic dysfunction has been insufficiently utilized by many clinicians, despite the high prevalence of insulin resistance, impaired glucose tolerance, metabolic syndrome, type 2 diabetes, and dyslipidemia in PCOS patients compared with their healthy counterparts
Key disclosures from company terms include: MEDVi states it does not directly provide medical or pharmacy services Payment does not guarantee the writing or dispensing of a prescription The site identifies itself as "an advertisement for services and not any specific medication" OpenLoop Health clinicians retain the decision to prescribe compounded GLP-1s to patients Entity Structure According to MEDVi's terms of use: "MEDVi does not provide any Healthcare Services through the Platform and is not licensed to practice medicine." MEDVi, LLC: Technology platform providing intake coordination, customer service, and payment processing OpenLoop Health: According to company disclosures, provides the network of licensed medical providers who conduct evaluations and make prescribing decisions Partner compounding pharmacies: According to the website, MEDVi partners with "multiple USA certified pharmacies" Pricing (As of December 26, 2025) Cost considerations are separate from medical appropriateness and should not influence prescribing decisions
8, S5S14
Privacy Policy/California Privacy Notice
El tratamiento se inicia con la dosis ms baja durante el primer mes y, por lo general, se va aumentando hasta alcanzar la dosis ms alta al cabo de 5 meses
US$ 27.93
US$ 23.89
US$ 28.39
US$ 23.07
